Drug Shortage Report for TRIZIVIR
Report ID | 90619 |
Drug Identification Number | 02244757 |
Brand name | TRIZIVIR |
Common or Proper name | abacavir (as abacavir sulfate), lamivudine and zidovudine tablets |
Company Name | VIIV HEALTHCARE ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ZIDOVUDINE ABACAVIR LAMIVUDINE |
Strength(s) | 300MG 300MG 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60's |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-08-23 |
Estimated end date | Unknown |
Actual end date | 2019-09-17 |
Shortage status | Resolved |
Updated date | 2021-12-08 |
Company comments | This product has been discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-877-393-8448 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-12-08 | French | Compare |
v13 | 2021-12-08 | English | Compare |
v12 | 2021-12-08 | French | Compare |
v11 | 2021-12-08 | English | Compare |
v10 | 2019-09-18 | French | Compare |
v9 | 2019-09-18 | English | Compare |
v8 | 2019-08-24 | English | Compare |
v7 | 2019-08-23 | French | Compare |
v6 | 2019-08-23 | English | Compare |
v5 | 2019-08-16 | French | Compare |
v4 | 2019-08-16 | English | Compare |
v3 | 2019-08-02 | French | Compare |
v2 | 2019-08-02 | French | Compare |
v1 | 2019-08-02 | English | Compare |
Showing 1 to 14 of 14